Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Financial Other
confidence 75%
filed 2026-10-21
Item 8.01
This disclosure reports a failed remarketing of class A-5 notes issued by the trust, resulting in mandatory retention of notes by existing holders and a reset to a failed remarketing rate (SOFR plus 0.75% per annum). While this is a financial event affecting the terms and cost of the trust's outstanding debt obligations, it does not fit the specific categories of debt_issuance (no new debt created), covenant_breach (no violation alleged), or material_impairment. The failed remarketing is a material financial event that affects noteholders' returns and the trust's obligations, warranting classification as financial_other.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-10-21
Item 8.01
The filing discloses a failed remarketing of class A-5 notes issued by the trust, resulting in a mandatory reset of the notes' interest rate to the failed remarketing rate (SOFR plus 0.75% per annum) and a three-month reset period. This is a material financial event affecting the terms and economics of the outstanding debt securities, but does not fit the specific categories of debt_issuance (no new debt created), covenant_breach (no violation alleged), or other named financial types. It is clearly a financial matter involving modification of existing debt terms.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-10-21
Item 8.01
FDA approval of HIBSAGO (bepirovirsen), a first-in-class hepatitis B treatment licensed from Ionis to GSK in 2019, represents a significant regulatory and commercial milestone for Ionis. Ionis is eligible for regulatory and sales milestone payments plus tiered royalties of 10-12% on net sales, materially affecting the company's future revenue streams and pipeline value.
View raw filing on EDGAR →
8-K
Operational Other
confidence 82%
filed 2026-10-21
Item 8.01
Navient announced a corporate reorganization establishing a new holding company structure (Navient Holdings, Inc.) to separate legacy and continuing businesses into two subsidiaries. The reorganization is conducted under Delaware law Section 251(g) without stockholder approval, with existing shares converting one-for-one with uninterrupted trading. This material strategic restructuring is designed to improve organizational efficiency and strategic flexibility.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-10-21
Item 2.02
The filing discloses quarterly financial results for the period ending September 30, 2026 via a press release attached as Exhibit 99(a). This is a standard earnings release disclosure under Item 2.02 (Results of Operations and Financial Condition), which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-21
Item 5.02
The filing discloses the appointment of Kaz Nejatian as President of Opendoor Technologies, effective October 21, 2026, in addition to his existing roles as CEO and Board member. While the section also describes Lucas Matheson's departure from the President role and his transition to an Advisor position with severance protections, the principal disclosed action centers on the appointment of Nejatian to the President role. This is material as it represents a significant change in executive leadership structure and reporting relationships.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-21
Item 2.02
Elevance Health issued a press release on October 21, 2026 reporting third quarter 2026 financial results, including operating revenue of $50.4 billion, diluted EPS of $6.27, and raised full-year 2026 guidance for diluted EPS to at least $22.00 and adjusted diluted EPS to at least $29.00. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the earnings release furnished as Exhibit 99.1, which is the standard disclosure mechanism for quarterly earnings announcements.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-21
Item 2.02
CME Group disclosed third-quarter 2026 financial results via press release attached as Exhibit 99.1, reporting revenue of $1.7 billion, operating income of $1.1 billion, net income of $1.0 billion, and diluted EPS of $2.89. The filing explicitly states this is a quarterly earnings release with detailed consolidated financial statements and reconciliations of non-GAAP measures, which is the hallmark of an earnings_release event under Item 2.02.
View raw filing on EDGAR →
6-K
Earnings release
confidence 75%
filed 2026-10-21
EX-99.1
This is an announcement of an upcoming third quarter 2026 financial results release scheduled for November 12, 2026, with a conference call on November 13, 2026. While the actual results are not disclosed in this exhibit, the press release announces the timing and logistics for the earnings announcement, which is a standard precursor to an earnings release event. The disclosure identifies the CEO and CFO who will discuss performance, making it a material announcement of forthcoming financial results.
View raw filing on EDGAR →
6-K
Financial Other
confidence 75%
filed 2026-10-21
EX-99.1
This press release announces a significant increase in the Company's estimated net asset value (NAV) to $258.0 million, a 41% increase from the previously reported NAV as of July 16, 2026. The disclosure includes NAV per share ($20.49 basic, $3.58 fully-diluted) and highlights a substantial discount between the current stock price and estimated NAV. While NAV is a non-GAAP metric commonly used in the shipping industry to track asset values and measure loan-to-value compliance, this material revaluation of the Company's asset base would affect a reasonable investor's assessment of the registrant's financial position and intrinsic value. The event does not fit a specific named financial category (not earnings results, debt issuance, dividend, or impairment charge) but is clearly a significant financial disclosure warranting classification as financial_other.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 80%
filed 2026-10-21
Item 1.01
On October 15, 2026, the Company entered into a Second Amendment to its Credit Agreement providing $5.0 million in incremental term loans for general corporate purposes, maturing October 30, 2030. The amendment also includes covenant waivers and extensions, reflecting underlying financial considerations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 72%
filed 2026-10-21
Item 8.01
The Company redeemed and retired Asset Backed Notes issued by an indirect subsidiary (ACM Auto Trust 2024-2) pursuant to an October 2024 indenture with Deutsche Bank, releasing approximately $92 million in pledged receivables and materially altering the Company's capital structure and debt position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-21
Item 2.02
Beacon Financial Corporation announced third quarter 2026 earnings results with net income of $61.2 million ($0.73 EPS) and operating earnings of $64.7 million ($0.77 operating EPS), along with disclosure of a quarterly dividend of $0.3225 per share and an increase in stock buyback authorization to $125 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-21
Item 2.02
This is a clear earnings release for Q3 2026 (quarter ended September 30, 2026) filed under Item 2.02. The press release discloses comprehensive financial results including record net sales of $5.21 billion (up 13% sequentially), diluted EPS of $7.84 (up 118% year-over-year), and pretax income of $531.9 million (up 115% year-over-year), along with detailed management commentary and forward guidance for Q4 2026. The exhibit is explicitly identified as the Company's press release announcing financial results for the period.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 92%
filed 2026-10-21
This 6-K discloses Eni's execution of a shareholder-approved treasury share repurchase program during October 12–16, 2026. The report explicitly states the shares were acquired "for the purpose of paying to the Shareholders an additional remuneration compared to the distribution of dividends, resolved by the same Shareholders' Meeting." The acquisition of 3.9 million shares for €100 million in this tranche, and 85.3 million shares (2.82% of capital) cumulatively since May 8, 2026, represents a material capital return to shareholders through a buyback program approved at the May 6, 2026 shareholder meeting.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-21
Item 2.02
Martin Midstream Partners issued a press release on October 21, 2026, reporting financial results for the third quarter ended September 30, 2026, including net loss of $4.1 million, Adjusted EBITDA of $23.6 million, upward revision of full-year 2026 guidance to $94 million, and declaration of a quarterly cash distribution of $0.005 per unit. This is a standard quarterly earnings disclosure furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
6-K
Financial Other
confidence 75%
filed 2026-10-21
RedHill regained ex-North America rights to RHB-102 through termination of a licensing agreement with Hyloris, receiving a $200,000 break-up fee and recovering full worldwide rights to the asset. This is a material financial and strategic event involving recovery of intellectual property rights and a cash payment, but does not fit the specific categories of M&A activity, debt issuance, or other named financial events. The restoration of full worldwide development rights to a late-stage oncology asset is material to investor assessment of the company's pipeline and strategic position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-21
Item 2.02
Molina Healthcare issued a press release on October 21, 2026 reporting third quarter 2026 financial results, including GAAP net income of $38 million ($0.73 per diluted share) and adjusted net income of $46 million ($0.89 per diluted share), along with reaffirmation of full-year 2026 earnings guidance of at least $5.25 per diluted share adjusted earnings. This is a standard quarterly earnings disclosure under Item 2.02, with the full press release attached as Exhibit 99.1.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-10-21
The Company completed a disposition of its indirect wholly-owned subsidiary Bondly Enterprises Limited on October 12, 2026, transferring all issued and outstanding shares to a third party. This constitutes a material change of control and divestiture under Item 1.02 / 2.01 of the 8-K taxonomy. The filing explicitly states "the Company no longer holds any equity interest in the Target," confirming the transaction's completion and the elimination of a subsidiary from the corporate structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-21
Item 5.02
Allen Kaplan was elected Chief Financial Officer effective November 1, 2026, with a base salary of $280,000, performance bonus, supplemental bonus, and equity awards (RSUs and PSUs). The appointment was announced via press release and represents a material transition in senior financial leadership.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-10-21
The 6-K discloses a Board resolution by Shinhan Bank (a wholly-owned subsidiary) declaring an interim cash dividend of KRW 630.67 per common share, with an aggregate amount of KRW 1 trillion and a record date of November 5, 2026. This is a material dividend distribution to shareholders, meeting the definition of `dividend_distribution` — declaration of a dividend to holders.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-10-21
Item 5.02
Fehmi Zeko resigned from the Board of Directors effective October 23, 2026, after seven years of service, and Gilbert Vasquez declined reelection at the 2027 Annual Meeting after 19 years of service, including as Audit Committee Chair.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-21
Item 7.01
Brian Krzanich (former Intel and CDK Global executive) and Gary Ferrera (30+ years of CFO experience) were appointed to the Board of Directors effective October 14, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-10-21
Item 2.01
Nuburu Defense completed the acquisition of 745,759 shares of Tekne S.p.A. on October 15, 2026, increasing ownership from approximately 2.9% to 70% for a fixed purchase price of €5,200,000 plus contingent earn-out consideration of up to €20,000,000 over ten years, resulting in a controlling interest in the company.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-10-21
Item 3.01
NYSE Regulation issued a public warning letter on October 19, 2026 citing violations of Section 401(a) disclosure requirements and explicitly warning that any future violation will result in immediate suspension and commencement of delisting proceedings.
View raw filing on EDGAR →
8-K
Operational Other
confidence 65%
filed 2026-10-21
Item 1.01
Nuburu entered into a material definitive agreement; the specific nature of the agreement cannot be determined from available information but is classified as an operational arrangement.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-10-21
EX-99.1
This exhibit is an announcement that Lufax will release its third quarter 2026 financial results on October 27, 2026, with a management earnings conference call scheduled for the same date. While this is technically a pre-announcement rather than the results themselves, it is the formal notice of an upcoming earnings release and is customarily classified as an earnings_release event in 6-K filings. The disclosure is material as quarterly financial results are core to investor assessment of the registrant's performance.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-10-21
ChipMOS disclosed the acquisition of machinery equipment and related accessories totaling NT$1,237,950 thousand and disposal of NT$58,557 thousand from K-SHINE ELECTRONIC CORPORATION (a non-related party) for manufacturing purposes. The transaction exceeds NT$500 million and meets Taiwan Stock Exchange material information disclosure thresholds under Article 4, Paragraph 1, Item 20. This is a material operational/capital deployment event involving significant equipment investment, but does not fit the specific categories of M&A activity, debt issuance, or other named financial events.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-10-21
Item 2.02
Stifel Financial Corp. disclosed its third quarter 2026 financial results on October 21, 2026, reporting net revenues of $1.43 billion and net income of $224.8 million ($1.40 per diluted share). The press release (Exhibit 99.1) contains comprehensive quarterly financial statements, segment results, and management commentary, which is the standard format for earnings releases filed under Item 2.02. This is a material disclosure affecting investor assessment of the registrant's financial performance and position.
View raw filing on EDGAR →
6-K
Operational Other
confidence 72%
filed 2026-10-21
POSCO is clarifying media reports about a potential KRW 4 trillion HBI (Hot Briquetted Iron) production project in Western Australia. The company confirms it is reviewing feasibility of this low-carbon steel initiative but emphasizes no investment decision, business structure, or implementation schedule has been determined. This is a material operational/strategic disclosure regarding a potential major capital project, though the company has not yet committed to it. The clarification itself is the disclosed event—a response to rumors about a significant strategic initiative.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-10-21
This is a press release announcing Natuzzi's unaudited financial results for the second quarter ended June 30, 2026. The document discloses consolidated revenue of €60.0 million (down 23.3% YoY), an operating loss of €10.0 million (vs. €2.7 million loss in 2Q 2025), and gross margin compression from 34.0% to 29.6%. While the release also mentions several material events (CEO appointment, delisting review, shareholder capital contribution, asset disposal, restructuring plan), the primary disclosure is the quarterly earnings announcement with detailed financial tables and segment analysis. The material deterioration in financial performance and cash position (€18.9 million cash) would affect a reasonable investor's assessment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-10-21
Item 7.01
Worthington Steel issued a statement regarding the upcoming extraordinary general meeting of Klöckner & Co to vote on implementation of a domination and profit and loss transfer agreement (DPLTA) entered into on September 8, 2026. The statement discloses material acquisition activity—specifically a change-of-control transaction whereby Worthington Steel will acquire Klöckner & Co, subject to shareholder approval. The disclosure addresses the timing of the vote and Worthington's commitment regarding future voting if the DPLTA fails to achieve the required 75% majority, making this a material M&A disclosure under Item 1.01 or 2.01 framework.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-21
Item 5.02
Robin Swartz was appointed President of Voyager Therapeutics effective October 20, 2026, and is expected to succeed Alfred W. Sandrock, Jr. as CEO following receipt of initial safety data in Q1 2027. This is a material executive appointment involving a clear succession plan for the chief executive role. While the disclosure also includes compensatory arrangements (equity grants, salary, severance terms), the principal disclosed action centers on Swartz taking on the President role with anticipated CEO succession, making exec_appointment the most salient classification.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-10-21
EX-99.1
This press release announces a technical benchmark demonstrating that MindWalk's LensAI™ immunogenicity screening platform achieved significant performance and cost improvements (37% faster, 43% lower cost per sequence) on AMD EPYC processors compared to Intel alternatives. The disclosure highlights a deepening engineering relationship with AMD and describes how architectural improvements to the underlying ReefIQ™ platform enable cost reduction at enterprise scale. While primarily a product/technology announcement rather than a discrete corporate event, the material cost reduction (43%) on a "heavy workload" and its direct impact on enterprise platform margins and the company's path to "contracted, recurring revenue" make this operationally material to investors assessing the registrant's ability to scale its business model profitably.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
AB Private Lending Fund sold 28,277 unregistered Class I common shares of beneficial interest to feeder vehicles on October 1, 2026 for approximately $700,000, relying on Section 4(a)(2) and/or Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-10-21
Item 7.01
AB Private Lending Fund declared regular distributions to shareholders of common shares of beneficial interest, with $0.20 per share for Class I shares, record date October 30, 2026, and payment date November 30, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-21
Item 5.02
John M. Boushy was appointed as a Class II Director of Galaxy Gaming effective October 21, 2026. Boushy is a distinguished gaming industry executive with 45+ years of experience and significant prior roles at Harrah's, Ameristar, and Caesars. The appointment also coincided with the resignation of Meredith Brill from the Board effective October 20, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-10-21
Item 1.01
Smith & Wesson completed its acquisition of Savage Arms on October 21, 2026, for approximately $160 million in a merger transaction involving the issuance of approximately 9 million shares (19.99% of outstanding shares) and $42.4 million in cash. The transaction combines two iconic firearms manufacturers, creates a leading U.S. firearms manufacturer with combined revenue of $711 million and 2,227 employees, and results in immediate EPS accretion of $0.07 before synergies and $0.10 after synergies.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-21
Item 5.02
Michael D. Fertitta was appointed as a director effective immediately following the closing of the Savage Arms acquisition, with the Board expanding to seven directors. The appointment reflects investor rights tied to JDH Capital's 16.7% ownership stake resulting from the acquisition and includes service on the Nominations and Corporate Governance Committee.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-10-21
Item 8.01
The Board of Directors declared a 3% common stock dividend payable on November 23, 2026, to shareholders of record on November 5, 2026. This is a direct declaration and distribution of equity to shareholders, fitting squarely within the dividend_distribution category. Stock dividends are material capital allocation decisions that affect shareholder value and are routinely disclosed in 8-K filings.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-10-21
Item 8.01
CarMax Auto Funding LLC disclosed the closing of an asset-backed securitization on October 21, 2026, involving the issuance of $1,333,122,000 in aggregate principal amount of asset-backed notes across eight classes (A-1 through D) pursuant to an Indenture with U.S. Bank Trust Company. This constitutes creation of a new direct financial obligation through debt issuance, which is the hallmark of the debt_issuance event type. The transaction involved multiple ancillary agreements (Receivables Purchase Agreement, Sale and Servicing Agreement, Administration Agreement, etc.) typical of securitization structures, but the core material event is the issuance of the notes themselves.
View raw filing on EDGAR →
8-K
Financial Other
confidence 85%
filed 2026-10-21
Item 8.01
The filing discloses the Company's Net Asset Value (NAV) per share as of September 30, 2026, broken down by share class and with detailed component analysis. This is a routine but material financial disclosure for a REIT, showing NAV increased from $2.22 billion (August 31, 2026) to $2.38 billion (September 30, 2026), with per-share NAV rising across all classes. While not a specific event type like earnings release or impairment, this financial valuation disclosure would affect a reasonable investor's assessment of the registrant's asset value and performance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-10-21
Item 1.01
AB Private Credit Investors Corp entered into a material definitive agreement creating substantial new direct financial obligations, including $195 million in Class A-T Term Loans, up to $30 million in Class A-D Delayed Drawdown Term Loans, and up to $105.9 million in Subordinated Delayed Drawdown Notes, with maturity on September 30, 2035.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-21
VTEX announced the appointment of Leandro Balbinot to its Board of Directors, effective November 1, 2026. Balbinot is a seasoned executive with three decades of experience in technology and retail leadership at major companies including Amazon, Capital One, and McDonald's. Board appointments are material governance events that affect the registrant's leadership and strategic direction.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-10-21
Item 1.01
EverQuote entered into a Second Amendment to its Credit Agreement with Western Alliance Bank that materially modifies the existing debt facility by permitting the Company to repurchase up to $75 million in shares and make up to $15 million in investments—actions previously restricted under the original facility. This amendment to a material credit facility reflects improved financial position and lender confidence.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-10-21
Item 8.01
The Board of Directors authorized a $50 million share repurchase program for the Company's Class A common stock, representing a material capital return to shareholders and signaling management confidence in the company's financial position.
View raw filing on EDGAR →
8-K
Financial Other
confidence 72%
filed 2026-10-21
Item 7.01
The Company consummated a purchase of $15 million in liquidation amount trust preferred securities from BIMIZCI Fund LLC for $11.16 million on October 21, 2026. This is a material financial transaction involving the acquisition of debt-like securities (trust preferred securities), but it does not fit neatly into the specific categories of debt_issuance (which concerns creation of new obligations), ma_activity (which typically involves acquisitions of operating businesses or material dispositions), or other named financial event types. The transaction is material to investors as it represents a significant capital deployment and balance-sheet event, warranting classification as financial_other.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-21
Item 2.02
SouthState Bank Corporation issued a press release on October 21, 2026 announcing third quarter 2026 financial results, including net income of $224 million, diluted EPS of $2.30, ROAA of 1.29%, and detailed balance sheet and capital ratio information for the three- and nine-month periods ended September 30, 2026.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-10-21
Item 8.01
The Board of Directors declared a quarterly cash dividend on common stock of $0.66 per share, payable on November 13, 2026 to shareholders of record as of November 6, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-21
Item 5.02
Ms. Lori Anello was appointed by the Board of Managers of the Managing Owner to serve as Principal Financial and Accounting Officer of Invesco Capital Management LLC, effective October 22, 2026. While the disclosure also mentions Ms. Kelli Gallegos beginning a leave of absence, the principal action disclosed is the appointment of Anello to a key financial officer role. The appointment of a Principal Financial and Accounting Officer is material to investors as it affects the fund's financial oversight and reporting.
View raw filing on EDGAR →